Skip to main content

Table 1 Characteristics of study participants at baseline

From: Helicobacter pylori infection is not an independent risk factor of non-alcoholic fatty liver disease in China

Variables

Full sample (nā€‰=ā€‰71,633)

Matched sample (nā€‰=ā€‰29,974) a

H. pyloriāˆ’ (nā€‰=ā€‰46,888)

H. pyloriā€‰+ā€‰(nā€‰=ā€‰24,745)

P value

H. pyloriāˆ’ (nā€‰=ā€‰14,987)

H. pyloriā€‰+ā€‰(nā€‰=ā€‰14,987)

P value

Age

44.8ā€‰Ā±ā€‰13.3

46.5ā€‰Ā±ā€‰12.5

ā€‰<ā€‰0.001

47.3ā€‰Ā±ā€‰12.9

46.6ā€‰Ā±ā€‰12.2

Ā 

Male (%)

57.6

58.6

0.010

58.3

57.5

0.134

BMI (kg/m2)

23.8ā€‰Ā±ā€‰3.4

24.1ā€‰Ā±ā€‰3.4

ā€‰<ā€‰0.001

24.3ā€‰Ā±ā€‰3.3

24.2ā€‰Ā±ā€‰3.4

0.043

Year of screening exam (%)

Ā 

ā€‰<ā€‰0.001

Ā Ā Ā 

Ā 2015

20.8

21.7

Ā 

21.6

12.6

Ā 

Ā 2016

24.4

24.2

Ā 

48.1

27.1

Ā 

Ā 2017

19.3

18.7

Ā 

25.1

23.0

Ā 

Ā 2018

19.8

21.3

Ā 

4.8

24.5

Ā 

Ā 2019

18.8

17.3

Ā 

0.4

12.7

Ā 

Systolic BP (mmHg)

124.3ā€‰Ā±ā€‰19.5

125.9ā€‰Ā±ā€‰20.0

ā€‰<ā€‰0.001

127.1ā€‰Ā±ā€‰19.8

126.4ā€‰Ā±ā€‰20.0

Ā 

Diastolic BP (mmHg)

77.8ā€‰Ā±ā€‰11.4

78.9ā€‰Ā±ā€‰11.8

ā€‰<ā€‰0.001

79.7ā€‰Ā±ā€‰11.5

79.1ā€‰Ā±ā€‰11.8

Ā 

Hypertension (%)

13.7

15.1

ā€‰<ā€‰0.001

13.5

13.9

0.129

FBG (mM)

5.05ā€‰Ā±ā€‰1.27

5.18ā€‰Ā±ā€‰1.47

ā€‰<ā€‰0.001

5.11ā€‰Ā±ā€‰1.29

5.12ā€‰Ā±ā€‰1.29

Ā 

HbA1C (%)

5.48ā€‰Ā±ā€‰0.75

5.55ā€‰Ā±ā€‰0.83

ā€‰<ā€‰0.001

5.50ā€‰Ā±ā€‰0.77

5.50ā€‰Ā±ā€‰0.77

Ā 

Diabetes (%)

4.74

6.14

ā€‰<ā€‰0.001

5.49

5.60

0.565

Total cholesterol (mM)

4.80ā€‰Ā±ā€‰0.92

4.86ā€‰Ā±ā€‰0.92

ā€‰<ā€‰0.001

4.89ā€‰Ā±ā€‰0.91

4.86ā€‰Ā±ā€‰0.92

Ā 

LDL-C (mM)

2.76ā€‰Ā±ā€‰0.77

2.82ā€‰Ā±ā€‰0.78

ā€‰<ā€‰0.001

2.22ā€‰Ā±ā€‰0.77

2.82ā€‰Ā±ā€‰0.77

Ā 

HDL-C (mM)

1.43ā€‰Ā±ā€‰0.34

1.41ā€‰Ā±ā€‰0.34

ā€‰<ā€‰0.001

1.46ā€‰Ā±ā€‰0.35

1.41ā€‰Ā±ā€‰0.35

Ā 

Triglycerides (mM)

1.58ā€‰Ā±ā€‰1.39

1.65ā€‰Ā±ā€‰1.50

ā€‰<ā€‰0.001

1.65ā€‰Ā±ā€‰1.41

1.64ā€‰Ā±ā€‰1.44

Ā 

Dyslipidemia (%)

24.9

28.0

ā€‰<ā€‰0.001

26.8

26.9

0.887

AST (IU/L)

23.3 (18ā€“25)

23.4 (18ā€“25)

0.011

22.7 (17ā€“25)

23.3 (18ā€“26)

Ā 

ALT (IU/L)

26.5 (15ā€“31)

27.0 (15ā€“31)

ā€‰<ā€‰0.001

27.4 (15ā€“32)

27.0 (15ā€“31)

Ā 

GGT (IU/L)

30.2 (14ā€“33)

31.0 (15ā€“35)

ā€‰<ā€‰0.001

32.6 (15ā€“36)

30.5 (14ā€“35)

Ā 

Scr (Ī¼M)

70.5ā€‰Ā±ā€‰17.2

71.1ā€‰Ā±ā€‰20.1

0.001

69.6ā€‰Ā±ā€‰18.6

70.2ā€‰Ā±ā€‰17.6

Ā 

BUN (mM)

4.88ā€‰Ā±ā€‰1.30

4.95ā€‰Ā±ā€‰1.37

ā€‰<ā€‰0.001

4.99ā€‰Ā±ā€‰1.32

4.94ā€‰Ā±ā€‰1.32

Ā 

NAFLD (%)

31.3

34.8

ā€‰<ā€‰0.001

34.8

34.6

0.716

  1. Continuous variables were shown as meanā€‰Ā±ā€‰SD or median (interquartile range), and categorical variables were expressed as counts (percentage)
  2. aMatched sample were selected with propensity score matching analysis (PSM) (Covariate: Age, sex, BMI, Systolic BP, Diastolic BP, FBG, HbA1C, Total cholesterol, LDL-C, HDL-C, Triglycerides, Scr, BUN; Matching tolerance: 0.001)
  3. H. pylori, Helicobacter pylori; BMI, body mass index; BP, blood pressure; FBG, fasting blood glucose; HbA1C, glycated hemoglobin; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; Scr, serum creatinine; BUN, blood urea nitrogen; NAFLD, nonalcoholic fatty liver disease